Featured Editorial

  1. Edge AI Is Reshaping How Clinical Trials Run 3/12/2026

    Edge computing and AI are transforming clinical trials – enabling real time monitoring, decentralized research, and faster, more cost-effective drug development.

  2. How Deep Learning Is Changing Clinical Trial Design, Execution, And Analysis In 2026 3/10/2026

    Deep learning is reshaping clinical trial design, execution, and analysis. Learn how to deploy it safely, measurably, and at scale with help from life sciences consultant and MIT industry advisor Partha Anbil.

  3. Telehealth In Clinical Trials: What Sites And Patients Think 3/4/2026

    Sites and patients have complicated views on telehealth in trials. Here’s what the evidence shows about who benefits, who bears the burden, and where the limits are.

  4. Pick The Right PV Technology With Help From A Safety Data Management Expert 2/27/2026

    Otsuka's Head of U.S. GPV Safety Data Management Vikalp Khare shares how smart governance should inform pharmacovigilance (PV) technology choices.

  5. Telehealth In Clinical Trials: What You Need To Know 2/26/2026

    Telehealth is a tool, not a trial design. Learn how televisits, ePRO, and remote monitoring fit into traditional, hybrid, and decentralized clinical trials.

  6. Enabling Cloud Computing In DCTs For Remote Data Capture, Monitoring, And More (Part 1) 2/25/2026

    Understand why cloud infrastructure is foundational to hybrid and decentralized trials and what critical trial activities it enables with reduced operational friction.

  7. Safe And Sustainable DCTs and Hybrid Trials (Part 2) 2/25/2026

    In part two of this series, learn practical cloud architectural patterns, governance structures, and operating mechanisms that allow sponsors to run hybrid and decentralized trials.

  8. Forget More Clinical Tech, We Need More Adoption 2/23/2026

    At SCOPE Summit, Craig Lipset shared a blunt assessment of clinical trial innovation: the tools exist, regulators are engaged, and digital approaches offer clear quality advantages — yet adoption remains the industry’s biggest hurdle. From evolving FDA inspection expectations to the normalization (and lingering misconceptions) of decentralized trials, Lipset argues progress will depend less on new technology and more on scaling what already works.

  9. Joe Dustin: Sites Are Driving Clinical Tech Evolution 2/20/2026

    At SCOPE Summit 2026, Joe Dustin shared why clinical trial sites are emerging as the next drivers of innovation. As sites digitize operations and push back against the burden of sponsor-mandated systems, new models like “bring your own technology” and seamless digital data flow aim to reduce duplication, speed startup, and improve both coordinator and patient experiences.

  10. How Salk And Sabin Helped Create The Modern Clinical Trial 2/17/2026

    How Jonas Salk and Albert Sabin pioneered double-blind methodology, HeLa cell assays, and IBM data processing – innovations that became the global standard for clinical trials.